Please try another search
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.
Name | Age | Since | Title |
---|---|---|---|
Jinliang Wang | 58 | 2016 | Non-Employee Supervisor |
Xiaodong Gao | 51 | 2008 | GM & Chairman of the Board |
Zuolin Wang | - | - | Independent Director |
Yanbin Liu | 62 | 2009 | Vice Chairman |
Shuxuan Gao | 47 | 2018 | Chairman of the Supervisory Board |
Xiangjun Wang | 60 | 2021 | Independent Director |
Yunxia Sun | 43 | 2021 | Deputy GM & Non-Independent Director |
Deying Cao | 65 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review